FDA Clearance Tracker · K170567
Tempus Pro Patient Monitor
Last checked: Nov 20, 2026Latest source record: Jul 6, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jul 6, 2017
Substantially Equivalent
Time to decision
129 days
Received Feb 27, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K170567
- Device name
- Tempus Pro Patient Monitor
- Applicant location
- Basingstoke, GB
- Received
- Feb 27, 2017
- Decided
- Jul 6, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1025
- Specialty
- CardiologyElectrophysiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MHX. The earliest in FDA's data is K872476, decided Sep 21, 1987.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K170567
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Remote Diagnostic Technologies , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Tempus LS - Manual510(k)
K200849 · Decided Jul 24, 2020 · 115 days after receipt
Device type: Dc-Defibrillator, Low-Energy, (Including Paddles) (LDD) · Cardiology
K173768 · Decided Jan 10, 2018 · 30 days after receipt
Device type: Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms) (MHX) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.